Current medical therapy of inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

294

HTML

2232

Figures (1-2)

577

Tables (1-1)

376

Sum=3479

Aug 15, 2000 (publication date) through Nov 5, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 15, 2000; 6(4): 483-489
Published online Aug 15, 2000. doi: 10.3748/wjg.v6.i4.483

Table 1 Medical therapy in IBD

Sulfasalazine and 5-amino salicylates	Azulfidine
	Olsalazine, Asacol, Pentasa, Balsalazide
Corticosteroids	Hydrocortisone, ACTH, Prednisone, Budesonide
Immunosuppressive/Immunomodulators Immuran/6MP, Cyclosporin A, Methotrexate,
	Anti-TNFα Antibody, (Remicade, CD P571)
	FK506, IL-10, IL-11
	IL-1 Receptor Antagonist, Anti-CD4 Antibody
Antibiotics	Metronidazole, Ciprofloxacin,Clarithromycin,
	Trimethoprim-sulfamethoxazole
New potential drugs	Nicotine
	Heparin
	ISIS 2302 (ICAM-1 inhibitor)
	Hydroxychloroquine, Leukotrienes inhibitors,
	Short chain fatty acids
	Antioxidants & free radical scavengers
	Probiotics

Citation: Das KM, Farag SA. Current medical therapy of inflammatory bowel disease. World J Gastroenterol 2000; 6(4): 483-489
URL: https://www.wjgnet.com/1007-9327/full/v6/i4/483.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i4.483